文献速递心境障碍焦虑、强迫与应激相关障碍

美国苯二氮䓬类药物配药全国趋势(2013—2024)

National Trends in Benzodiazepine Dispensing.
PubMed 文献 · Am J Psychiatry · 2026-09-30

该研究基于IQVIA纵向处方数据集,对2013—2024年间共1,100,233,787次苯二氮䓬类(BZD)处方配药进行重复横断面分析,按患者年龄和处方者类型分层。结果显示,美国BZD年度配药患病率从7.5%降至5.5%,相对下降26.7%,各年龄组均净下降,18—29岁年轻成人相对降幅最大(-44.8%)。每张BZD处方的平均总剂量在所有年龄和处方者类型中均下降,疼痛医学专家降幅达-65.3%。

要点

  • 2013—2024年美国BZD配药患病率相对下降26.7%,从7.5%降至5.5%。
  • 18—29岁年轻成人相对降幅最大(-44.8%),各年龄组均呈净下降。
  • 高级实践提供者开具的BZD数量相对增加101.5%,而疼痛医学专家、初级保健医生和精神科医生均大幅下降。

核心结论

  • 过去十年美国BZD处方配药数量和总剂量全国性下降,可能反映配药更谨慎或更具选择性,或与安全性考虑和药品标签变更有关。

研究设计与样本

  • 采用IQVIA纵向处方数据集进行重复横断面分析,评估2013—2024年BZD处方配药趋势,共纳入1,100,233,787次处方配药。

主要发现

  • BZD年度配药患病率从2013年的7.5%降至2024年的5.5%,相对下降26.7%。
  • 各年龄组患病率均净下降,18—29岁年轻成人相对降幅最大(-44.8%)。
  • 初级保健医生开具BZD处方最多,其次为高级实践提供者和精神科/心理健康专家。
  • 疼痛医学专家(-62.5%)、初级保健医生(-44.3%)和精神科/心理健康专家(-38.3%)开具的BZD数量相对大幅下降,高级实践提供者增加101.5%。
  • 每张BZD处方的平均总剂量在所有患者年龄和处方者类型中均下降,疼痛医学专家开具剂量降幅达-65.3%。

临床怎么用

  • 临床应关注BZD配药持续下降的趋势,尤其是在年轻成人中,同时注意高级实践提供者开具BZD增加的变化。
  • 针对特定患者和处方者群体的配药模式变化需持续监测,以评估处方实践改进的需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Benzodiazepines (BZDs) are commonly prescribed medications in the United States. Up-to-date BZD dispensing trends can inform whether and where improvements in prescribing practices are needed. The objective of this study was to evaluate national changes in BZD dispensing from 2013 to 2024 by patient age and prescriber type. METHODS: A repeated, cross-sectional analysis using the IQVIA Longitudinal Prescription dataset was conducted to examine trends in BZD prescription dispensing between 2013 and 2024 (a total of 1,100,233,787 prescription fills). BZD prescription fill counts, prevalence, and mean total dose dispensed per BZD prescription were reported annually, stratified by patient age and prescriber type. RESULTS: From 2013 to 2024, the annual U.S. prevalence of BZDs dispensed declined by 26.7%, from 7.5% to 5.5%. Net decreases in prevalence occurred across age groups, with the largest relative reduction among young adults ages 18-29 (-44.8%). Primary care physicians dispensed the most BZD prescriptions, followed by advanced practice providers and psychiatrists/mental health specialists. There were sharp relative declines in the number of BZDs dispensed by pain medicine specialists (-62.5%), primary care physicians (-44.3%), and psychiatrists/mental health specialists (-38.3%), with an increase observed among advanced practice providers (+101.5%). The mean total dose dispensed per BZD prescription decreased across all patient ages and prescriber types, with large declines in doses prescribed by pain medicine specialists (-65.3%). CONCLUSIONS: National declines in BZD prescription fills and total dose dispensed over the past decade may indicate greater caution or selectiveness in BZD dispensing, potentially related to safety considerations and drug labeling changes. Shifts in dispensing patterns among select patient and prescriber populations warrant ongoing monitoring.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cruz N, Samples H, Crystal S, et al. National Trends in Benzodiazepine Dispensing. Am J Psychiatry. 2026. PMID: 42811410. doi:10.1176/appi.ajp.20251346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。